Achondroplasia is a disorder of bone growth that prevents the changing of cartilage (particularly in the long bones of the arms and legs) to bone. It is characterized by dwarfism, limited range of motion at the elbows, large head size (macrocephaly), small fingers, and normal intelligence.
This report contains market size and forecasts of Achondroplasty Treatment Drug in global, including the following market information:
Global Achondroplasty Treatment Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Achondroplasty Treatment Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Achondroplasty Treatment Drug companies in 2021 (%)
The global Achondroplasty Treatment Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
RBM-007 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Achondroplasty Treatment Drug include BioMarin Pharmaceutical and Ribomic etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Achondroplasty Treatment Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Achondroplasty Treatment Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Achondroplasty Treatment Drug Market Segment Percentages, by Type, 2021 (%)
RBM-007
TA-46
B-701
Others
Global Achondroplasty Treatment Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Achondroplasty Treatment Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Achondroplasty Treatment Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Achondroplasty Treatment Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Achondroplasty Treatment Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Achondroplasty Treatment Drug revenues share in global market, 2021 (%)
Key companies Achondroplasty Treatment Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Achondroplasty Treatment Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioMarin Pharmaceutical
Ribomic